Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
作者:
关键词
ALDH1BRCA1CICSCEGFRFFPEFIGOH&EHGSCHRHigh-grade serous carcinomaIRSInternational Federation of Gynaecology and ObstetricsMECOCTIPSOSOvarianOvarian Cancer Therapy Innovative Models Prolong SurvivalPrognosisTMATNBCaldehyde dehydrogenase 1breast cancer antigen 1cancer stem cellconfidence intervalepidermal growth factor receptorformalin-fixed, paraffin-embeddedhazard ratiohematoxylin and eosinhigh-grade serous carcinomaimmunoreactivity scoremammary epithelial cellsoverall survivaltissue microarraytriple-negative breast cancer
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);囊腺癌, 浆液(Cystadenocarcinoma, Serous);女(雌)性(Female);人类(Humans);免疫组织化学(Immunohistochemistry);同工酶类(Isoenzymes);Kaplan-Meiers评估(Kaplan-Meier Estimate);中年人(Middle Aged);卵巢肿瘤(Ovarian Neoplasms);预后(Prognosis);比例危险度模型(Proportional Hazards Models);视黄醛脱氢酶(Retinal Dehydrogenase)
DOI
10.1016/j.humpath.2012.12.016
PMID
23465277
发布时间
2022-03-18
- 浏览146

Human pathology
1465-71页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文